“Empiric” inositol supplementation in normal-weight non insulin resistant women with polycystic ovarian disease: from the absence of benefit to the potential adverse effects

Archives of Gynecology and Obstetrics

Volumn 291, Issue 5, 2015, Pages 955-957

  Vitagliano, Amerigo ^a   Quaranta, Michela ^b   Noventa, Marco ^a   Gizzo, Salvatore ^a,c  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c Clinica di Ostetricia e Ginecologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; FOLLITROPIN; GLUCOSE; INOSITOL; INSULIN; LUTEINIZING HORMONE; FOLIC ACID; VITAMIN B COMPLEX;

ANDROGEN BLOOD LEVEL; BODY MASS; DIET SUPPLEMENTATION; ENDOMETRIOSIS; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LETTER; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUAL CYCLE; OOCYTE; OVARY FOLLICLE DEVELOPMENT; OVARY POLYCYSTIC DISEASE; OVULATION; OXIDATIVE STRESS; THECA CELL; FEMALE; MENSTRUATION DISTURBANCES; OVARY; PATHOPHYSIOLOGY; POLYCYSTIC OVARY SYNDROME;

FEMALE; FOLIC ACID; HUMANS; INOSITOL; MENSTRUATION DISTURBANCES; OVARY; POLYCYSTIC OVARY SYNDROME; VITAMIN B COMPLEX;

EID: 84925539849     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-015-3662-9     Document Type: Letter

References (20)

1. Laganà AS, Barbaro L, Pizzo A (2014) Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with d-chiro-inositol. Arch Gynecol Obstet. doi:10.1007/s00404-014-3552-6
2. Iuorno MJ, Jakubowicz DJ, Baillargeon JP, Dillon P, Gunn RD, Allan G, Nestler JE (2002) Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome. Endocr Pract 8(6):417–423
3. Pizzo A, Laganà AS, Barbaro L (2014) Comparison between effects of myo-inositol and d-chiro-inositol on ovarian function and metabolic factors in women with PCOS. Gynecol Endocrinol 30(3):205–208
4. Genazzani AD, Prati A, Santagni S, Ricchieri F, Chierchia E, Rattighieri E, Campedelli A, Simoncini T, Artini PG (2012) Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients. Gynecol Endocrinol 28(12):969–973
5. Rondanelli M, Perna S, Faliva M, Monteferrario F, Repaci E, Allieri F (2014) Focus on metabolic and nutritional correlates of polycystic ovary syndrome and update on nutritional management of these critical phenomena. Arch Gynecol Obstet 290(6):1079–1092
6. Baptiste CG, Battista MC, Trottier A, Baillargeon JP (2010) Insulin and hyperandrogenism in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol 122(1–3):42–52
7. Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G (1999) Ovulatory and metabolic effects of d-chiro-inositol in the polycystic ovary syndrome. N Engl J Med 340(17):1314–1320
8. Qiao J, Feng HL (2011) Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update 17(1):17–33
9. Piomboni P, Focarelli R, Capaldo A, Stendardi A, Cappelli V, Cianci A et al (2014) Protein modification as oxidative stress marker in follicular fluid from women with polycystic ovary syndrome: the effect of inositol and metformin. J Assist Reprod Genet 31(10):1269–1276
10. Jancar N, Kopitar AN, Ihan A, VirantKlun I, Bokal EV (2007) Effect of apoptosis and reactive oxygen species production in human granulosa cells on oocyte fertilization and blastocyst development. J Assist Reprod Genet 24(2–3):91–97
11. Hennet ML, Yu HY, Combelles CM (2013) Follicular fluid hydrogen peroxide and lipid hydroperoxide in bovine antral follicles of various size, atresia, and dominance status. J Assist Reprod Genet 30(3):333–340
12. Vitagliano A, Noventa M, Gizzo S (2014) Is it time to consider patients suffering from endometriosis-related infertility as “novel candidates” for targeted peri-conceptional D-chiro inositol supplementation? Hypothesis, rationale and some considerations. J Assist Reprod Genet. doi:10.1007/s10815-014-0412-z
13. Nehra D, Le HD, Fallon EM, Carlson SJ, Woods D, White YA, Pan AH, Guo L, Rodig SJ, Tilly JL, Rueda BR, Puder M (2012) Prolonging the female reproductive lifespan and improving egg quality with dietary omega-3 fatty acids. Aging Cell 11(6):1046–1054
14. Huang B, Li Z, Ai J, Zhu L, Li Y, Jin L, Zhang H (2014) Antioxidant capacity of follicular fluid from patients undergoing in vitro fertilization. Int J Clin Exp Pathol 7(5):2273–2282
15. Palini S, Benedetti S, Tagliamonte MC, De Stefani S, Primiterra M, Polli V, Rocchi P, Catalani S, Battistelli S, Canestrari F, Bulletti C (2014) Influence of ovarian stimulation for IVF/ICSI on the antioxidant defence system and relationship to outcome. Reprod Biomed Online 29(1):65–71
16. Gizzo S, Capuzzo D, Zicchina C, Di Gangi S, Coronella ML, Andrisani A, Gangemi M, Nardelli GB (2014) Could empirical low-dose-aspirin administration during IVF cycle affect both the oocytes and embryos quality via COX 1-2 activity inhibition? J Assist Reprod Genet 31(3):261–268
17. Chen L, Xu WM, Zhang D (2014) Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome. Fertil Steril 102(4):1167–1174.e4
18. Ciotta L, Stracquadanio M, Pagano I, Carbonaro A, Palumbo M, Gulino F (2011) Effects of myo-inositol supplementation on oocyte’s quality in PCOS patients: a double blind trial. Eur Rev Med Pharmacol Sci 15(5):509–514
19. Isabella R, Raffone E (2012) Does ovary need d-chiro-inositol? J Ovarian Res 5(1):14
20. Lisi F, Carfagna P, Oliva MM, Rago R, Lisi R, Poverini R, Manna C, Vaquero E, Caserta D, Raparelli V, Marci R, Moscarini M (2012) Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study. Reprod Biol Endocrinol 23(10):52